Results 71 to 80 of about 61,250 (205)
International consensus statement on idiopathic pulmonary fibrosis [PDF]
Ulrich Costabel, Talmadge E. King
openalex +1 more source
A scoring system using eight clinical variables was developed and validated to predict 30‐day mortality in acute exacerbation of idiopathic pulmonary fibrosis. The model showed good performance in both derivation and validation cohorts, providing a practical bedside tool for early risk stratification.
Joong‐Yub Kim+13 more
wiley +1 more source
Idiopathic Pulmonary Fibrosis Challenges for the Future [PDF]
Moisés Selman
openalex +1 more source
This prospective cohort study of 246 F‐ILD patients assessed disease impact using PROMs (SGRQ, SF‐36) and functional measures (1MSTS and 6MWD). Tree‐based learning identified mortality predictors, outperforming the GAP score. Patients with SGRQ > 34.5 and 1MSTS < 21 had a significantly higher mortality risk (HR = 5.13).
Lan‐Yan Yang+3 more
wiley +1 more source
Idiopathic pulmonary fibrosis - Part 2: Treatment [PDF]
H. Lode, R Erbes, M. Raffenberg
openalex +1 more source
ABSTRACT Background and Objective Fatigue significantly impacts quality of life in fibrosing interstitial lung diseases (fILDs). Oxyhaemoglobin desaturation contributes to fatigue in chronic obstructive pulmonary disease; however, this has not been investigated in fILD.
Shohei Kawachi+2 more
wiley +1 more source
Idiopathic pulmonary fibrosis - Part 1: Diagnosis [PDF]
R Erbes, M. Raffenberg, H. Lode
openalex +1 more source
A polymorphism of DSP was associated with prognosis and acute exacerbation in Japanese individuals with idiopathic pulmonary fibrosis (IPF), and a polymorphism of TERT was associated with prognosis in the patients with IPF and acute exacerbation in those with unclassifiable idiopathic interstitial pneumonias, indicating the potential of personalised ...
Kazuya Tsubouchi+18 more
wiley +1 more source
Serum surfactant proteins‐A and ‐D as biomarkers in idiopathic pulmonary fibrosis [PDF]
Kelly E. Greene+7 more
openalex +1 more source
ABSTRACT Introduction In nonendemic areas, transplantation from donors with hepatitis B virus (HBV) to recipients without HBV (D+/R−) has been proposed to expand the donor pool; however, data are limited. We aimed to evaluate the epidemiology of HBV in thoracic organ donors, assess HBV‐related thoracic organ nonuse, and determine the impact of HBV D+/R−
Sara Belga+4 more
wiley +1 more source